This topic covers the use of advanced AI systems—from domain-adapted models like OpenAI Rosalind to enterprise ML platforms and observability tools—to support biodefense and biosecurity functions while managing dual‑use risks and regulatory obligations. It focuses on how organizations deploy private, auditable models and orchestrated agents to detect threats, accelerate incident response, and maintain compliance without amplifying misuse. Relevance (2026): proliferating multimodal and agentic AIs, broader access to high‑capacity foundation models, and growing regulatory scrutiny have made operational controls and governance central to biosecurity programs. The tools and approaches described by vendors emphasize: visibility into agentic activity (Xilos), private and efficient foundation models for enterprise use and fine‑tuning (Mistral AI, Cohere), assistant-driven automation and multi‑agent workflows (IBM watsonx Assistant), managed multimodal model access and lifecycle controls (Google Gemini, Vertex AI), and safety‑oriented conversational frameworks (Anthropic’s Claude). Together these capabilities support secure model deployment, provenance tracking, retrieval‑augmented workflows, and audit trails expected by regulators and incident response teams. Key trends and practical considerations include integrating observability and policy enforcement across toolchains, using vetted AI marketplaces and compliance tooling to limit third‑party risk, and pairing domain‑tuned models with stringent access controls and logging. Rather than a single product solution, effective biodefense architectures in 2026 combine private foundation models, orchestration platforms, and monitoring systems to balance operational value with governance, traceability, and regulatory compliance.